期刊文献+

腺相关病毒载体介导siRNA抑制HBV表达和复制的研究

Inhibition effect of adeno-associated virus vector mediated siRNA on the replication and expression of hepatitis B virus
下载PDF
导出
摘要 目的构建能抑制HBVm RNA表达的siRNA-重组腺相关病毒(rAAV)表达载体,观察重组病毒对HBV的抑制作用。方法将设计好的siRNA克隆到骨架质粒pAAV-MC中,将该质粒与pAAV-RC和pHelper质粒共同转染人胚肾293T细胞,进行病毒包装。收获并纯化病毒,感染模型细胞HepG2.215,采用ELISA法和荧光定量PCR法检测包装的rAAV-shRNA-GFP病毒抑制HBV情况。结果经酶切及测序证实,rAAV载体质粒pAAV-shRNA-GFP构建成功,包装的rAAV-shRNA-GFP病毒感染HepG2.215细胞后,可以抑制HBsAg、HBeAg的表达和HBV的复制。结论成功制备出rAAV-shRNA-GFP病毒,其能够抑制HBV的表达和复制。 Objective To construct the recombinant adeno-associated virus( rAAV) vectors for siRNA targeting hepatitis B virus( HBV) mRNA and to observe the inhibitive effect on HBsAg and HbeAg expression and replication of HBV in vitro. Methods The pAAV-shRNA-GFP expressing plasmid was constructed by molecular biological techniques. This plasmid combined with pAAV-RC and pHelper were transfected into human embryonic kidney 293T cells using LipofecLamineTM 2000. The rAAV-shRNA-GFP was packaged,amplified and purified,which was used to infect HepG 2. 2. 15 cells. The inhibitory effect of this recombinant on HBV was analyzed by ELISA and fluorescence quantitative RCR. Results The result of restriction enzyme digestion and sequencing showed that the recombinant adeno-associated virus vector plasmid pAAV-shRNA-GFP was successfully constructed. After the HepG2. 2. 15 cells were infected by purified rAAVshRNA-GFP virus,the copies of HBV DNA and RNA and HBsAg and HBeAg expression were significantly inhibited. Conclusion The rAAV-shRNA-GFP virus which is successfully constructed can effectively inhibit the replication and expression of HBV in vitro.
作者 李琴山 田硕
出处 《山东医药》 CAS 2013年第37期12-14,17,共4页 Shandong Medical Journal
基金 贵州省中医药管理局基金项目(QZYY2010-64)
关键词 腺相关病毒2 RNA干扰 正嗜肝DNA病毒属 基因疗法 adeno-associated virus 2 RNA interference orthohepad navirus genetic therapy
  • 相关文献

参考文献22

  • 1Fire A,Xu S,Montgomery MK. Potent and specific interference by double-stranded RNA in Caenorhabditis elegans[J].{H}NATURE,1998,(6669):806-811.
  • 2Chen Y,Cheng G,Mahato RI. RNAi for treating hepatitis B viral infection[J].{H}Pharmaceutical Research,2008,(1):72-86.
  • 3Carmona S,Ely A,Crowther C,eta1. Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs[J].{H}Molecular Therapy,2006,(2):411-421.
  • 4Peng J,Zhao Y,Mai J. Inhibition of hepatitis B virus replication by various RNAi constructs and their pharmacodynamic properties[J].{H}Journal of General Virology,2005,(Ptl2):3227-3234.
  • 5Shlomai A,Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference[J].{H}HEPATOLOGY,2003,(4):764-770.
  • 6涂燕,李振江,汤爱萍,李慧慧,贺文凤,李洁,张冉.细胞外基质金属蛋白酶诱导因子RNAi慢病毒载体的构建[J].山东医药,2011,51(33):16-18. 被引量:3
  • 7Hudu SA,Malik YA,Niazlin MT. An overview of hepatitis B virus surface antigen mutant in the Asia Pacific[J].{H}Current Issues Mol Biol,2013,(2):69-78.
  • 8Seto WK,Tanaka Y,Wong DK. Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay[J].Hepatol Int,2012,(1):98-105.
  • 9Lou X,Hou Y,Liang D. Effects of hepatitis B virus X protein on human T cell cytokines[J].{H}Canadian Journal of Microbiology,2013,(9):620-626.
  • 10Hong SJ,Kim YH,Choe BH. Current role of Lamivudine regarding therapeutic response and resistance in children with chronic hepatitis B[J].Pediatr Gastroenterol Hepatol Nutr,2013,(2):80-88.

二级参考文献2

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部